Related references
Note: Only part of the references are listed.Hippocampal volume in vulnerability and resilience to depression
Stella W. Y. Chan et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Antidepressant Medication May Moderate the Effect of Depression Duration on Hippocampus Volume
Mark A. Rogers et al.
JOURNAL OF PSYCHOPHYSIOLOGY (2016)
Neuropathological relationship between major depression and dementia: A hypothetical model and review
Helena Kyunghee Kim et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Duration of untreated depression influences clinical outcomes and disability
Lucio Ghio et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
The impact of the duration of an untreated episode on improvement of depression and somatic symptoms
Ching-I Hung et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2015)
Factors predicting adherence to antidepressant treatment
Ching-I Hung
CURRENT OPINION IN PSYCHIATRY (2014)
Duration of untreated illness and outcomes in unipolar depression: A systematic review and meta-analysis
Lucio Ghio et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Frontal-insula gray matter deficits in first-episode medication-naive patients with major depressive disorder
Chien-Han Lai et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
The effect of prolonged duration of untreated depression on antidepressant treatment outcome
Jens Drachmann Bukh et al.
JOURNAL OF AFFECTIVE DISORDERS (2013)
State-dependent changes in hippocampal grey matter in depression
D. Arnone et al.
MOLECULAR PSYCHIATRY (2013)
Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: Results from the CO-MED trial
Edward S. Friedman et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
The cut-off points of the Depression and Somatic Symptoms Scale and the Hospital Anxiety and Depression Scale in detecting non-full remission and a current major depressive episode
Ching-I. Hung et al.
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2012)
Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study
Alfredo Carlo Altamura et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2010)
A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes
Javier de Diego-Adelino et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder
Akiko Okuda et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
May duration of untreated illness influence the long-term course of major depressive disorder?
A. Carlo Altamura et al.
EUROPEAN PSYCHIATRY (2008)
Duration of untreated illness in major depressive disorder: a naturalistic study
A. C. Altamura et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2007)
The naturalistic course of unipolar major depression in the absence of somatic therapy
Michael A. Posternak et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Untreated depression and hippocampal volume loss
YI Sheline et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes
TA Furukawa et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
Share Paper
